We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant

Delisted

CYTXW was delisted on the 14th of December, 2018.

0 hedge funds and large institutions have $0 invested in Cytori Therapeutics Inc Warrant in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 40 (-4)

100% less capital invested

Capital invested by funds: $1K → $0 (-$1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
Holders Change
-4
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
-$1K -176,649 Closed

CYTXW Hedge Fund Activity: Q4 2018 in Review

0 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q4 2018, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CYTXW and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $1K sold.

  • 0 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q4 2018, down from 4 in Q3 2018.
  • Funds reported $0 of Cytori Therapeutics Inc Warrant stock for Q4 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Cytori Therapeutics Inc Warrant positions in Q4 2018 and 4 closed out, a net change of -4 holders.
  • The largest Cytori Therapeutics Inc Warrant seller in Q4 2018 was Susquehanna International Group, an estimated $1K sold.

Based on aggregated 13F filings for Q4 2018.